SMAP
Amplify Small-Mid Cap Equity ETF
The Amplify Small-Mid Cap Equity ETF seeks to provide investors with long-term capital appreciation by investing primarily in U.S. small and mid-cap equities that exhibit strong growth potential.
US
EQUITY
Active
MANAGEMENT STYLE
$ 1.3 M
ASSETS UNDER MGMT
60 bp
EXPENSES
Fund Basics
| Inception date | Oct 22, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| MONOLITHIC POWER SYSTEMS INC | 4.7 % |
| MKS INSTRUMENTS INC | 3.4 % |
| CASEY'S GENERAL STORES INC | 3.2 % |
| STIFEL FINANCIAL CORP | 3.0 % |
| WEST PHARMACEUTICAL SERVICES | 3.0 % |
| CURTISS-WRIGHT CORP | 3.0 % |
| WATSCO INC | 2.9 % |
| MATADOR RESOURCES CO | 2.7 % |
| AMERICAN FINANCIAL GROUP INC | 2.5 % |
| REPLIGEN CORP | 2.4 % |
Constituent Breakdown
| Number of holdings | 55 |
| Herfindahl-Hirschman Index | 218 |
| Wgt avg mkt cap (mns) | $16,078 |
| Large cap (>$10bn) | 60.8% |
| Mid cap ($2-10bn) | 34.1% |
| Small cap (<$2bn) | 3.8% |
| Developed mkts. | 99.2% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 98.1 % |
 |
SWITZERLAND | 1.0 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -1.1% | 5.7% | -- | -- | -- | -- | -- | 297.9% |
| Dividend Yield | 0.1% | 0.5% | -- | -- | -- | -- | -- | 0.3% |
| Total Returns | -1.0% | 6.2% | -- | -- | -- | -- | -- | 298.2% | Ann. Volatility | 18.2% | 21.1% | -- | -- | -- | -- | -- | 527.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.97 | 77% |
| MSCI EAFE | 0.91 | 58% |
| MSCI Emg Mkts | 0.72 | 48% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 2.0% |
| Avg. Bid/Ask (% of price) | 0.39% |
Technical Indicators
| 30d moving avg. (EMA) | $24.91 |
| Relative strength (RSI) | 54 |
| MACD/Signal | 0.05/-0.17 |
| Bollinger Bands (Upper/Lower) | $25.57/$23.44 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. SMAP |
Expenses vs. SMAP |
ALTAR Score™ vs. SMAP |
|---|---|---|---|---|
| MDCP | VictoryShares THB Mid Cap ESG ETF | 17.0% | -5 bp | 0.0% |
| XMHQ | Invesco S&P MidCap Quality ETF | 14.0% | -35 bp | +2.1% |
| GLRY | Inspire Faithward Mid Cap Momentum ETF | 13.9% | +20 bp | -0.3% |
| SCDV | Bahl & Gaynor Small Cap Dividend ETF | 13.4% | +10 bp | -0.5% |
| OSCV | Opus Small Cap Value ETF | 13.3% | +19 bp | +1.2% |
| REGL | ProShares S&P MidCap 400 Dividend Aristocrats ETF | 12.6% | -20 bp | +2.1% |
| CSMD | Congress SMid Growth ETF | 12.3% | +9 bp | -0.7% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 10.8% | -50 bp | +0.0% |
| SMCO | Hilton Small-MidCap Opportunity ETF | 10.4% | -5 bp | +0.0% |
| XMMO | Invesco S&P MidCap Momentum ETF | 10.4% | -26 bp | -0.8% |
Risk and Returns: SMAP vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/12/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.0%
ALTAR SCORE™
39th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.6% and a standard deviation
of 2.1%. SMAP's ALTAR Score™ is approximately -0.3 standard
deviations above the category average. This places SMAP in the 39th percentile
among funds in the category.
Sell-Side Consensus
$30.33
PRICE TARGET
+18.8%
UPSIDE